Moreover, zinc reduces hypoxia-inducible factor-1α in prostate cancer cells and can have apoptotic effects by activating caspase-3 and caspase-9, and increasing levels of Bax protein, a pro-apoptotic protein; hence elevating the Bax/Bcl-2 ratio [112]. This evidence concerns the gene BCL2 and prostate carcinoma.